Checkpoint Inhibitor Immunotherapy Toxicity and Overall Survival among Older Adults with Advanced Cancer

OBJECTIVES: Despite growing evidence that checkpoint inhibitor immunotherapy (IO) toxicity is associated with improved treatment response, the relationship between immune-related adverse events (irAEs) and overall survival (OS) among older adults [age ≥ 70 years (y)] remains unknown. The study goal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Geriatr Oncol
Main Authors: Johns, Andrew C., Wei, Lai, Grogan, Madison, Hoyd, Rebecca, Bridges, John F.P., Patel, Sandipkumar H., Li, Mingjia, Husain, Marium, Kendra, Kari L., Otterson, Gregory A., Burkart, Jarred T., Rosko, Ashley E., Andersen, Barbara L., Carbone, David P., Owen, Dwight H., Spakowicz, Daniel J., Presley, Carolyn J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8184608/
https://ncbi.nlm.nih.gov/pubmed/33627226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2021.02.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados